The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Children Influenza Vaccine Market Research Report 2025

Global Children Influenza Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1767226

No of Pages : 90

Ask Your Query

Synopsis
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global Children Influenza Vaccine market is projected to reach US$ 2090.9 million in 2029, increasing from US$ 1597 million in 2022, with the CAGR of 3.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Children Influenza Vaccine market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Children Influenza Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Sanofi
  • CSL
  • GSK
  • Viatris
  • Hulan Bio
  • AstraZeneca
  • CCBIO
  • Sinovac
  • BCHT
  • Jiangsu GDK
  • KM Biologics

Segment by Type

  • Nasal Spray
  • Injection

Segment by Application

  • Public
  • Private

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Children Influenza Vaccine report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Children Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Children Influenza Vaccine
1.2 Children Influenza Vaccine Segment by Type
1.2.1 Global Children Influenza Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Nasal Spray
1.2.3 Injection
1.3 Children Influenza Vaccine Segment by Application
1.3.1 Global Children Influenza Vaccine Market Value by Application: (2023-2029)
1.3.2 Public
1.3.3 Private
1.4 Global Children Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Children Influenza Vaccine Revenue 2018-2029
1.4.2 Global Children Influenza Vaccine Sales 2018-2029
1.4.3 Global Children Influenza Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Children Influenza Vaccine Market Competition by Manufacturers
2.1 Global Children Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Children Influenza Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Children Influenza Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Children Influenza Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Children Influenza Vaccine, Product Type & Application
2.7 Children Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Children Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Children Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Children Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Children Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Children Influenza Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Children Influenza Vaccine Global Children Influenza Vaccine Sales by Region: 2018-2029
3.2.1 Global Children Influenza Vaccine Sales by Region: 2018-2023
3.2.2 Global Children Influenza Vaccine Sales by Region: 2024-2029
3.3 Global Children Influenza Vaccine Global Children Influenza Vaccine Revenue by Region: 2018-2029
3.3.1 Global Children Influenza Vaccine Revenue by Region: 2018-2023
3.3.2 Global Children Influenza Vaccine Revenue by Region: 2024-2029
3.4 North America Children Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Children Influenza Vaccine Sales by Country (2018-2029)
3.4.3 North America Children Influenza Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Children Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Children Influenza Vaccine Sales by Country (2018-2029)
3.5.3 Europe Children Influenza Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Children Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Children Influenza Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Children Influenza Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Children Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Children Influenza Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Children Influenza Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Children Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Children Influenza Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Children Influenza Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Children Influenza Vaccine Sales by Type (2018-2029)
4.1.1 Global Children Influenza Vaccine Sales by Type (2018-2023)
4.1.2 Global Children Influenza Vaccine Sales by Type (2024-2029)
4.1.3 Global Children Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Children Influenza Vaccine Revenue by Type (2018-2029)
4.2.1 Global Children Influenza Vaccine Revenue by Type (2018-2023)
4.2.2 Global Children Influenza Vaccine Revenue by Type (2024-2029)
4.2.3 Global Children Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Children Influenza Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Children Influenza Vaccine Sales by Application (2018-2029)
5.1.1 Global Children Influenza Vaccine Sales by Application (2018-2023)
5.1.2 Global Children Influenza Vaccine Sales by Application (2024-2029)
5.1.3 Global Children Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Children Influenza Vaccine Revenue by Application (2018-2029)
5.2.1 Global Children Influenza Vaccine Revenue by Application (2018-2023)
5.2.2 Global Children Influenza Vaccine Revenue by Application (2024-2029)
5.2.3 Global Children Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Children Influenza Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Children Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Children Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GSK Children Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Viatris Children Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Description and Business Overview
6.5.3 Hulan Bio Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hulan Bio Children Influenza Vaccine Product Portfolio
6.5.5 Hulan Bio Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AstraZeneca Children Influenza Vaccine Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 CCBIO
6.6.1 CCBIO Corporation Information
6.6.2 CCBIO Description and Business Overview
6.6.3 CCBIO Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CCBIO Children Influenza Vaccine Product Portfolio
6.7.5 CCBIO Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sinovac Children Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Corporation Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BCHT Children Influenza Vaccine Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Corporation Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Jiangsu GDK Children Influenza Vaccine Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Corporation Information
6.11.2 KM Biologics Children Influenza Vaccine Description and Business Overview
6.11.3 KM Biologics Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 KM Biologics Children Influenza Vaccine Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Children Influenza Vaccine Industry Chain Analysis
7.2 Children Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Children Influenza Vaccine Production Mode & Process
7.4 Children Influenza Vaccine Sales and Marketing
7.4.1 Children Influenza Vaccine Sales Channels
7.4.2 Children Influenza Vaccine Distributors
7.5 Children Influenza Vaccine Customers
8 Children Influenza Vaccine Market Dynamics
8.1 Children Influenza Vaccine Industry Trends
8.2 Children Influenza Vaccine Market Drivers
8.3 Children Influenza Vaccine Market Challenges
8.4 Children Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock